Drug Reference
Hyoscyamine / Methenamine / Methylene Blue / Phenyl Salicylate / Sodium Phosphate, Monobasic
Brand names
PhosphasalUrelleUretron DSUribelUrimar Reformulated Oct 2013Urin DSUstellUtira
Available as
0.12 MG · Oral Tablet0.12 MG · Oral Capsule
Multi-ingredient product
HyoscyamineMethenamineMethylene BluePhenyl SalicylateSodium Phosphate, Monobasic
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- URETRON D/S (METHENAMINE, SODIUM PHOSPHATE MONOBASIC, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE) TABLET [DORAL PHARMAMEDICS INC DBA A.G. MARIN PHARMACEUTICALS]
- URO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]
- URELLE (HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIATRIS SPECIALTY LLC]
- MB CAPS (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE) CAPSULE [ALLEGIS PHARMACEUTICALS, LLC]
- URIMAR-T CAPS (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE) CAPSULE [ALLEGIS PHARMACEUTICALS, LLC]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.